Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation

Liver Transplantation

Volumn 14, Issue 1, 2008, Pages 46-52

  Parker, Brian M ^a,b   Cywinski, Jacek B ^a   Alster, Joan M ^a   Irefin, Samuel A ^a   Popovich, Marc ^a   Beven, Michael ^a   Fung, John J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INDOCYANINE GREEN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NON INVASIVE PROCEDURE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; REPERFUSION;

BIOPSY; COLORING AGENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOCYANINE GREEN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 38649111678     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21308     Document Type: Article

References (19)

1. Liu S, Frye RF, Branch RA, Venkataramanan R, Fung JJ, Burkhart GJ. Effect of age and postoperative time on cytochrome P450 enzyme activity following liver transplantation. J Clin Pharmacol 2005;45:666-673.
2. Burkhart GJ, Frye RF, Kelly P, Branch RA, Jain A, Fung JJ, et al. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther 1998;63:296-302.
3. Abu-Elmagd KM, Fung JJ, Alessiani M, Jain A, Takaya S, Venkataramanan R, et al. Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc 1991;23:2771-2774.
4. The Organ Procurement and Transplantation Network. Richmond (VA): OPTN data page; c2003. Available at: http://www.optn.org/data/. Accessed March 2007.
5. Burckart GJ, Liu XI. Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics? Ther Drug Monit 2006;28:23-30.
6. Jalan R, Plevris JN, Jalan AR, Finlayson ND, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994;58:196-200.
7. Oellerich M, Burdelski M, Lautz HU, Rodeck B, Duewel J, Schulz M, et al. Assessment of pre-transplant prognosis in patients with cirrhosis. Transplantation 1991;51:801-806.
8. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996;24:1165-1171.
9. Shinohara H, Tanata A, Kitai T, Yanabu N, Inomoto T, Satoh S, et al. Direct measurement of hepatic indocyanine green clearance with near infrared spectroscopy; separate evaluation of uptake and removal. Hepatology 1996;23: 137-144.
10. von Spiegel T, Scholz M, Wietasch G, Hering R, Allen SJ, Wood P, et al. Perioperative monitoring of indocyanine green clearance and plasma disappearance rate in patients undergoing liver transplantation. Anaesthesist 2002;51:359-366.
11. Herold C, Heinz R, Niedobitek G, Schneider T, Hahn EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with hepatitis B and C. Liver 2001;21:260-265.
12. Venkataramanan R, Shaw LM, Sarkozi L, Mullins R, Pirsch J, MacFarlane G, et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol 2001;41:542-551.
13. MacFarlane GD, Shaw LM, Venkataramanan R, Mullins R, Scheller DG, Ersfeld DL. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function. Ther Drug Monit 1999; 21:585-592.
14. Mandell MS, Wachs M, Niemann CU, Henthorn TK. Elimination of indocyanine green in the perioperative evaluation of donor liver function. Anesth Analg 2002;95:1182-1184.
15. Chan MT, Gin T, Chiu AK, Lau WY. Pitfalls of indocyanine green dye elimination to assess graft function during liver transplantation. Anaesth Analg 2003;96:1839-1841.
16. Uusaro A, Ruokonen E, Takala J. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995;30: 106-112.
17. Hadengue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993;17:175-178.
18. Krenn CG, Schafer B, Berklakovich GA, Steininger R, Steltzer H, Spiss CK. Detection of graft nonfunction after liver transplantation by assessment of indocyanine green kinetics. Anesth Analg 1998;87:34-36.
19. Plevris JN, Jalan R, Bzeizi KI, Dollinger MM, Lee A, Garden OJ, et al. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 1999;30: 142-148.